Hitting Multiple Immune System Targets with a Passively Targeted, Pulsed, Systemic Approach to Amplify Efficacy & Widen the Therapeutic Index
Time: 9:15 am
day: Conference Day 2
Details:
- Taking advantage of multiple TLR/STING agonists, passive targeting and rapid clearance associated with bacteria
- Activation of both innate and adaptive anti-tumor immunity, tumor eradication and immunological memory in pre-clinical models
- Confirmation of a pulse-prime mechanism and update on a Phase 1 clinical trial with Decoy20
